Cargando…
miR‐19b controls cardiac fibroblast proliferation and migration
Cardiac fibrosis is a fundamental constituent of a variety of cardiac dysfunction, making it a leading cause of death worldwide. However, no effective treatment for cardiac fibrosis is available. Therefore, novel therapeutics for cardiac fibrosis are highly needed. Recently, miR‐19b has been found t...
Autores principales: | Zhong, Chongjun, Wang, Kun, Liu, Ying, Lv, Dongchao, Zheng, Bo, Zhou, Qiulian, Sun, Qi, Chen, Ping, Ding, Shengguang, Xu, Yiming, Huang, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882982/ https://www.ncbi.nlm.nih.gov/pubmed/27061862 http://dx.doi.org/10.1111/jcmm.12858 |
Ejemplares similares
-
MiR-222 in Cardiovascular Diseases: Physiology and Pathology
por: Ding, Shengguang, et al.
Publicado: (2017) -
Neuroepithelial Cell Transforming Gene 1 Acts as an Oncogene and Is Mediated by miR-22 in Human Non-Small-Cell Lung Cancer
por: Ding, Shengguang, et al.
Publicado: (2020) -
Cardiac telocytes are double positive for CD34/PDGFR-α
por: Zhou, Qiulian, et al.
Publicado: (2015) -
miR‐149 controls non‐alcoholic fatty liver by targeting FGF‐21
por: Xiao, Junjie, et al.
Publicado: (2016) -
Cardiac Telocytes and Fibroblasts in Primary Culture: Different Morphologies and Immunophenotypes
por: Bei, Yihua, et al.
Publicado: (2015)